1
|
Peterson JA, Crowther CM, Andrus MB, Kenealey JD. Resveratrol derivatives increase cytosolic calcium by inhibiting plasma membrane ATPase and inducing calcium release from the endoplasmic reticulum in prostate cancer cells. Biochem Biophys Rep 2019; 19:100667. [PMID: 31463373 PMCID: PMC6709415 DOI: 10.1016/j.bbrep.2019.100667] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2019] [Revised: 07/15/2019] [Accepted: 07/16/2019] [Indexed: 12/16/2022] Open
Abstract
Resveratrol (RES) is a putative chemotherapeutic naturally found in grapes, peanuts, and Japanese knotweed. Previous studies demonstrate that RES modulates calcium signaling as part of its chemotherapeutic activity. In this study, we determined the chemotherapeutic activity of three RES esters that have been modified at the 4' hydroxyl by the addition of pivalate, butyrate, and isobutyrate. All of the RES derivatives disrupted the calcium signaling in prostate cancer cells more than the parent compound, RES. Further, we demonstrate that the RES derivatives may disrupt the calcium homeostasis by activating calcium release from the endoplasmic reticulum and inhibiting plasma membrane Ca2+-ATPase. The pivalated and butyrated RES derivatives decreased cell viability significantly more than RES. Because pivalated and butyrated RES are more effective than RES at targeting calcium signaling pathways, pivalated and butyrated RES may serve as more effective chemotherapeutics.
Collapse
Key Words
- 2-APB, 2-Aminoethyl diphenylborinate
- AUC, area under the curve
- BuRV, 4′-butyrate resveratrol
- Calcium signaling
- DMEM, Dulbecco's modified Eagle medium
- DMSO, dimethyl sulfoxide
- ER, endoplasmic reticulum
- FBS, fetal bovine serum
- Fura-2
- Fura-2, Fura-2-Acetoxymethyl ester
- HBSS, Ca2+- and Mg2+-free Hank's Balanced Salt Solution
- IP3, inositol triphosphate
- IP3R, inositol triphosphate receptor
- IsoRV, 4′-isobutyrate resveratrol
- MTT, 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- PBS, phosphate-buffered saline
- PIP2, phosphatidylinositol biphosphate
- PIV, 4′-pivalate resveratrol
- PLC, phospholipase C
- PMCA, plasma membrane Ca2+-ATPase
- Plasma membrane Ca2+-ATPase
- Prostate cancer
- RES, resveratrol
- Resveratrol
- SERCA, sarcoendoplasmic reticular Ca2+-ATPase
- TG, thapsigargin
- [Ca2+]i, cytosolic calcium concentration
Collapse
Affiliation(s)
- Joshua A Peterson
- Department of Nutrition, Dietetics and Food Science, Brigham Young University, Provo, UT, USA
| | - Colton M Crowther
- Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA
| | - Merritt B Andrus
- Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT, USA
| | - Jason D Kenealey
- Department of Nutrition, Dietetics and Food Science, Brigham Young University, Provo, UT, USA
| |
Collapse
|
2
|
Abstract
The intracellular calcium ions (Ca2+) act as second messenger to regulate gene transcription, cell proliferation, migration and death. Accumulating evidences have demonstrated that intracellular Ca2+ homeostasis is altered in cancer cells and the alteration is involved in tumor initiation, angiogenesis, progression and metastasis. Targeting derailed Ca2+ signaling for cancer therapy has become an emerging research area. This review summarizes some important Ca2+ channels, transporters and Ca2+-ATPases, which have been reported to be altered in human cancer patients. It discusses the current research effort toward evaluation of the blockers, inhibitors or regulators for Ca2+ channels/transporters or Ca2+-ATPase pumps as anti-cancer drugs. This review is also aimed to stimulate interest in, and support for research into the understanding of cellular mechanisms underlying the regulation of Ca2+ signaling in different cancer cells, and to search for novel therapies to cure these malignancies by targeting Ca2+ channels or transporters.
Collapse
Key Words
- 20-GPPD, 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol
- Apoptosis
- CBD, cannabidiol
- CBG, cannabigerol
- CPZ, capsazepine
- CRAC, Ca2+ release-activated Ca2+ channel
- CTL, cytotoxic T cells
- CYP3A4, cytochrome P450 3A4
- Ca2+ channels
- CaM, calmodulin
- CaMKII, calmodulin-dependent protein kinase II
- Cancer therapy
- Cell proliferation
- Channel blockers;
- ER/SR, endoplasmic/sarcoplasmic reticulum
- HCX, H+/Ca2+ exchangers
- IP3, inositol 1,4,5-trisphosphate
- IP3R (1, 2, 3), IP3 receptor (type 1, type 2, type 3)
- MCU, mitochondrial Ca2+ uniporter
- MCUR1, MCU uniporter regulator 1
- MICU (1, 2, 3), mitochondrial calcium uptake (type 1, type 2, type 3)
- MLCK, myosin light-chain kinase
- Migration
- NCX, Na+/Ca2+ exchanger
- NF-κB, nuclear factor-κB
- NFAT, nuclear factor of activated T cells
- NSCLC, non-small cell lung cancer
- OSCC, oral squamous cell carcinoma cells
- PKC, protein kinase C
- PM, plasma membrane
- PMCA, plasma membrane Ca2+-ATPase
- PTP, permeability transition pore
- ROS, reactive oxygen species
- RyR, ryanodine receptor
- SERCA, SR/ER Ca2+-ATPase
- SOCE, store-operated Ca2+ entry
- SPCA, secretory pathway Ca2+-ATPase
- Store-operated Ca2+ entry
- TEA, tetraethylammonium
- TG, thapsigargin
- TPC2, two-pore channel 2
- TRIM, 1-(2-(trifluoromethyl) phenyl) imidazole
- TRP (A, C, M, ML, N, P, V), transient receptor potential (ankyrin, canonical, melastatin, mucolipin, no mechanoreceptor potential C, polycystic, vanilloid)
- VGCC, voltage-gated Ca2+ channel
- mAb, monoclonal antibody
Collapse
Affiliation(s)
- Chaochu Cui
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
- Department of Surgery, Division of Thoracic Surgery, The Ohio State University, Columbus, OH 43210, USA
| | - Robert Merritt
- Department of Surgery, Division of Thoracic Surgery, The Ohio State University, Columbus, OH 43210, USA
- Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA
| | - Liwu Fu
- State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
| | - Zui Pan
- Department of Surgery, Division of Thoracic Surgery, The Ohio State University, Columbus, OH 43210, USA
- Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA
- College of Nursing and Health Innovation, The University of Texas at Arlington, Arlington, TX 76019, USA
| |
Collapse
|
3
|
Peterson JA, Oblad RV, Mecham JC, Kenealey JD. Resveratrol inhibits plasma membrane Ca 2+-ATPase inducing an increase in cytoplasmic calcium. Biochem Biophys Rep 2016; 7:253-258. [PMID: 28955914 PMCID: PMC5613515 DOI: 10.1016/j.bbrep.2016.06.019] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Revised: 06/17/2016] [Accepted: 06/29/2016] [Indexed: 02/03/2023] Open
Abstract
Plasma membrane Ca2+-ATPase (PMCA) plays a vital role in maintaining cytosolic calcium concentration ([Ca2+]i). Given that many diseases have modified PMCA expression and activity, PMCA is an important potential target for therapeutic treatment. This study demonstrates that the non-toxic, naturally-occurring polyphenol resveratrol (RES) induces increases in [Ca2+]i via PMCA inhibition in primary dermal fibroblasts and MDA-MB-231 breast cancer cells. Our results also illustrate that RES and the fluorescent intracellular calcium indicator Fura-2, are compatible for simultaneous use, in contrast to previous studies, which indicated that RES modulates the Fura-2 fluorescence independent of calcium concentration. Because RES has been identified as a PMCA inhibitor, further studies may be conducted to develop more specific PMCA inhibitors from RES derivatives for potential therapeutic use. Resveratrol induces a rise in [Ca2+]i via plasma membrane Ca2+-ATPase inhibition. FURA-2 is compatible with resveratrol in measuring [Ca2+]i. PMCA inhibition is novel to resveratrol among naturally occurring polyphenols.
Collapse
Key Words
- BAPTA, BAPTA-Acetoxymethyl ester
- Calcium signaling
- DMEM, Dulbecco's modified Eagle medium
- DMSO, dimethyl sulfoxide
- EGCG, epigallocatechin gallate
- ER, endoplasmic reticulum
- FBS, fetal bovine serum
- Fura-2
- Fura-2, Fura-2-Acetoxymethyl ester
- HBSS, Ca2+- and Mg2+-free Hank's Balanced Salt Solution
- PBS, phosphate-buffered saline
- PMCA, plasma membrane Ca2+-ATPase
- Plasma membrane Ca2+-ATPase
- RES, resveratrol
- ROI, region of interest
- Resveratrol
- SERCA, sarcoendoplasmic reticular Ca2+-ATPase
- TG, thapsigargin
- [Ca2+]i, cytosolic calcium concentration
Collapse
Affiliation(s)
- Joshua Allen Peterson
- Department of Nutrition, Dietetics and Food Science, Brigham Young University, ESC S-127, Provo, UT, United States
| | - Richard Vernon Oblad
- Department of Nutrition, Dietetics and Food Science, Brigham Young University, ESC S-127, Provo, UT, United States
| | - Jeffrey Chad Mecham
- Department of Nutrition, Dietetics and Food Science, Brigham Young University, ESC S-127, Provo, UT, United States
| | - Jason Donald Kenealey
- Department of Nutrition, Dietetics and Food Science, Brigham Young University, ESC S-127, Provo, UT, United States
| |
Collapse
|
4
|
Abstract
Mathematical modeling of the electrical activity of the pancreatic β-cell has been extremely important for understanding the cellular mechanisms involved in glucose-stimulated insulin secretion. Several models have been proposed over the last 30 y, growing in complexity as experimental evidence of the cellular mechanisms involved has become available. Almost all the models have been developed based on experimental data from rodents. However, given the many important differences between species, models of human β-cells have recently been developed. This review summarizes how modeling of β-cells has evolved, highlighting the proposed physiological mechanisms underlying β-cell electrical activity.
Collapse
Key Words
- ADP, adenosine diphosphate
- ATP, adenosine triphosphate
- CK, Chay-Keizer
- CRAC, calcium release-activated current
- Ca2+, calcium ions
- DOM, dual oscillator model
- ER, endoplasmic reticulum
- F6P, fructose-6-phosphate
- FBP, fructose-1,6-bisphosphate
- GLUT, glucose transporter
- GSIS, glucose-stimulated insulin secretion
- HERG, human eter à-go-go related gene
- IP3R, inositol-1,4,5-trisphosphate receptors
- KATP, ATP-sensitive K+ channels
- KCa, Ca2+-dependent K+ channels
- Kv, voltage-dependent K+ channels
- MCU, mitochondrial Ca2+ uniporter
- NCX, Na+/Ca2+ exchanger
- PFK, phosphofructokinase
- PMCA, plasma membrane Ca2+-ATPase
- ROS, reactive oxygen species
- RyR, ryanodine receptors
- SERCA, sarco-endoplasmic reticulum Ca2+-ATPase
- T2D, Type 2 Diabetes
- TCA, trycarboxylic acid cycle
- TRP, transient receptor potential
- VDCC, voltage-dependent Ca2+ channels
- Vm, membrane potential
- [ATP]i, cytosolic ATP
- [Ca2+]i, intracellular calcium concentration
- [Ca2+]m, mitochondrial calcium
- [Na+], Na+ concentration
- action potentials
- bursting
- cAMP, cyclic AMP
- calcium
- electrical activity
- ion channels
- mNCX, mitochondrial Na+/Ca2+ exchanger
- mathematical model
- β-cell
Collapse
Affiliation(s)
- Gerardo J Félix-Martínez
- Department of Electrical Engineering; Universidad
Autónoma Metropolitana-Iztapalapa; México, DF,
México
- Correspondence to: Gerardo J
Félix-Martínez;
| | | |
Collapse
|